Description of an In Vitro Platelet Function Analyzer-PFA-100™

Abstract

A new in vitro system for the detection of platelet dysfunction, PFA-100™^* has been developed. It provides a quantitative measure of platelet function in anticoagulated whole blood. The system comprises a microprocessor-controlled instrument and a disposable test cartridge containing a biologically active membrane. The instrument aspirates a blood sample under constant vacuum from the sample reservoir through a capillary and a microscopic aperture cut into the membrane. The membrane is coated with collagen and epinephrine or adenosine 5’-diphosphate. The presence of these biochemical stimuli, and the high shear rates generated under the standardized flow conditions, result in platelet attachment, activation, and aggregation, slowly building a stable platelet plug at the aperture. The time required to obtain full occlusion of the aperture is reported as the m“closure time.” We have found that impairment of von Willebrand factor, or inhibition of platelet receptors glycoprotein Ib or IIblIIIa with monoclonal antibodies or peptides, resulted in abnormal closure times. An antifibrinogen antibody, in contrast, failed to show any effect. The test appears to be sensitive to platelet adherence and aggregation abnormalities. The PFA-100™ system has potential applications in routine evaluation of platelet function in the clinical setting because of its accuracy, ease of operation, and rapid turnaround of results.

^* Under evaluation

Keywords

platelets - bleeding time - platelet function - PFA-100™ - Von Willebrand disease

• References

• 1 Kratzer MAA, Born GVR. Simulation of primary haemostasis in vitro. Haemostasis 15: 357-362 1985;
• 2 von der Goltz V U.S. Patent 5051239, 1991;
• 3 Dietrich G, Weber D, Kretschmer V. The in vitro bleeding test—standardization of the methodical procedure. Lab Med 17: 317-323 1993;
• 4 Kretschmer V, Schikor B, Söhngen D, Dietrich G. In vitro bleeding test - a simple method for the detection of aspirin effects on platelet function. Thromb Res 56: 593-602 1989;
• 5 Kundu S, Sio R, Mitu A, Ostgaard R. Evaluation of platelet function by PFA-100™. Clin Chern 40: 1827-1828 1994;
• 6 Kratzer MAA, Bellucci S, Caen JP. Detection of abnormal platelet functions with an in vitro model of primary haemostasis. Haemostasis 15: 363-370 1985;
• 7 Alshameeri R, Mammen EF. Evaluation of an in vitro bleeding time device. Thromb Haemost 69: 1146 1994; (abstr.)
• 8 Tsujinaka T, Itoh T, Ufmura Y, Sakon M, Kambayashi I, Mori T. Clinical application of a new in vitro bleeding time device on surgical patients. Ipn 1 Surg 18: 430-437 1988;